ESC Premium Access

Proprotein convertase subtilisin/kexin type 9 (PCSK9), platelet activation and risk of cardiovascular events in atrial fibrillation

Congress Presentation

About the speaker

Professor Pasquale Pignatelli Spinazzola

Sapienza University of Rome, Rome (Italy)
0 follower

71 more presentations in this session

Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy

Speaker: Doctor G. Chi (Boston, US)


Factor V Leiden related risk of thromboembolic and bleeding complications in patients with established coronary heart disease.

Speaker: Doctor B. Mahmoodi (Rotterdam, NL)


Factor V Leiden and prothrombin G20210A mutations in patients with premature myocardial infarction.

Speaker: Professor L. Rallidis (Athens, GR)


Angiographic and hemodynamic modifications of Myocardial Bridge during supine bicycle exercise

Speaker: Doctor J. Adjedj (Saint Laurent du Var, FR)


Intracoronary electrocardiographic parameters predict mortality rates at mid-term follow-up (up to 60 months) after stenting coronary bifurcation lesions

Speaker: Professor K. Karamfiloff (Sofia, BG)


Access the full session

Poster session 2 - Coronary artery disease: from bench to bedside

Speakers: Professor P. Pignatelli Spinazzola, Doctor G. Chi, Doctor B. Mahmoodi, Professor L. Rallidis, Doctor J. Adjedj...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by